Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10

BACKGROUND: The peptide apelin is expressed in human healthy livers and is implicated in the development of hepatic fibrosis and cirrhosis. Mutations in the bone morphogenetic protein receptor type II (BMPR-II) result in reduced plasma levels of apelin in patients with heritable pulmonary arterial h...

Descripción completa

Detalles Bibliográficos
Autores principales: Owen, Nicola E., Nyimanu, Duuamene, Kuc, Rhoda E., Upton, Paul D., Morrell, Nicholas W., Alexander, Graeme J., Maguire, Janet J., Davenport, Anthony P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Inc 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883214/
https://www.ncbi.nlm.nih.gov/pubmed/33171278
http://dx.doi.org/10.1016/j.peptides.2020.170440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883214/
https://www.ncbi.nlm.nih.gov/pubmed/33171278
http://dx.doi.org/10.1016/j.peptides.2020.170440

Ejemplares similares